"markets don't seem to care about lenzilumab [and leronlimab]"?! As both CYDY and HGEN stocks went from <$0.5 a few months ago to $5 and more now, with nothing but preliminary data and hopes pushing the SPs up.

Hard to call 1000% increases virtually overnight "not caring".